Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40


Taking Sides in E-cigarette Research.

Annechino R, Antin T.

Conf Proc Ethnogr Prax Ind Conf. 2016 Nov;2016(1):105-119. doi: 10.1111/1559-8918.2016.01079. Epub 2016 Nov 29.


Synthesis of graphene/DPA composite for determination of nicotine in tobacco products.

Jing Y, Yu B, Li P, Xiong B, Cheng Y, Li Y, Li C, Xiao X, Chen M, Chen L, Zhang Y, Zhao M, Cheng C.

Sci Rep. 2017 Oct 30;7(1):14332. doi: 10.1038/s41598-017-13716-2.


Smoking Isn't Cool Anymore: The Success and Continuing Challenge of Public Health Efforts to Reduce Smoking.

Cummings KM.

J Public Health Manag Pract. 2016 Jan-Feb;22(1):5-8. doi: 10.1097/PHH.0000000000000360. No abstract available.


A study of pyrazines in cigarettes and how additives might be used to enhance tobacco addiction.

Alpert HR, Agaku IT, Connolly GN.

Tob Control. 2016 Jul;25(4):444-50. doi: 10.1136/tobaccocontrol-2014-051943. Epub 2015 Jun 10.


Roadmap to a tobacco epidemic: transnational tobacco companies invade Indonesia.

Hurt RD, Ebbert JO, Achadi A, Croghan IT.

Tob Control. 2012 May;21(3):306-12. doi: 10.1136/tc.2010.036814. Epub 2011 Aug 18.


Factors associated with smoking menthol cigarettes among treatment-seeking African American light smokers.

Faseru B, Choi WS, Krebill R, Mayo MS, Nollen NL, Okuyemi KS, Ahluwalia JS, Cox LS.

Addict Behav. 2011 Dec;36(12):1321-4. doi: 10.1016/j.addbeh.2011.07.015. Epub 2011 Jul 22.


Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.

Henningfield JE, Hatsukami DK, Zeller M, Peters E.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):1-7. doi: 10.1016/j.drugalcdep.2010.12.009. Epub 2011 Mar 3.


Tobacco harm reduction and the evolution of nicotine dependence.

Parascandola M.

Am J Public Health. 2011 Apr;101(4):632-41. doi: 10.2105/AJPH.2009.189274. Epub 2011 Feb 17.


'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction.

Gundle KR, Dingel MJ, Koenig BA.

Addiction. 2010 Jun;105(6):974-83. doi: 10.1111/j.1360-0443.2010.02940.x.


Critical care support of patients with nicotine addiction.

Afessa B, Keegan MT.

Crit Care. 2010;14(3):155. doi: 10.1186/cc8955. Epub 2010 May 17.


Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

O'Connor RJ, Cummings KM, Rees VW, Connolly GN, Norton KJ, Sweanor D, Parascandola M, Hatsukami DK, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3334-48. doi: 10.1158/1055-9965.EPI-09-0429. Review.


Destroyed documents: uncovering the science that Imperial Tobacco Canada sought to conceal.

Hammond D, Chaiton M, Lee A, Collishaw N.

CMAJ. 2009 Nov 10;181(10):691-8. doi: 10.1503/cmaj.080566. Epub 2009 Oct 14. Review.


Open doorway to truth: legacy of the Minnesota tobacco trial.

Hurt RD, Ebbert JO, Muggli ME, Lockhart NJ, Robertson CR.

Mayo Clin Proc. 2009 May;84(5):446-56. doi: 10.1016/S0025-6196(11)60563-6. Review.


The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food?

Brownell KD, Warner KE.

Milbank Q. 2009 Mar;87(1):259-94. doi: 10.1111/j.1468-0009.2009.00555.x.


Corporate philanthropy, lobbying, and public health policy.

Tesler LE, Malone RE.

Am J Public Health. 2008 Dec;98(12):2123-33. doi: 10.2105/AJPH.2007.128231. Epub 2008 Oct 15. Review.


Waking a sleeping giant: the tobacco industry's response to the polonium-210 issue.

Muggli ME, Ebbert JO, Robertson C, Hurt RD.

Am J Public Health. 2008 Sep;98(9):1643-50. doi: 10.2105/AJPH.2007.130963. Epub 2008 Jul 16.

Supplemental Content

Support Center